Jutta Gartner

Title: Jutta Gartner: Innovator in Sulfatase Deficiency Treatments

Introduction

Jutta Gartner is a prominent inventor based in Göttingen, Germany. She has made significant contributions to the field of medical treatments, particularly focusing on diseases associated with sulfatase deficiencies. Her innovative approach has the potential to improve the lives of many individuals suffering from these conditions.

Latest Patents

Jutta Gartner holds a patent for a method aimed at treating diseases associated with sulfatase deficiencies. This method involves administering a therapeutically effective amount of at least one retinoid to individuals suffering from lysosomal storage diseases. Specifically, the compounds tazaroten and bexaroten have shown beneficial effects for these patients. The pharmaceutical compositions that include both active agents provide a ready treatment option, and enhanced results are achieved when at least two active agents are utilized.

Career Highlights

Jutta Gartner is affiliated with the Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin. Her work at this esteemed institution has allowed her to focus on groundbreaking research and development in the medical field.

Collaborations

Some of her notable coworkers include Lars Schlotawa and Matthias Kettwig. Their collaborative efforts contribute to the advancement of research in the treatment of sulfatase deficiencies.

Conclusion

Jutta Gartner's innovative work in developing treatments for sulfatase deficiencies highlights her dedication to improving patient care. Her contributions to medical science are invaluable and pave the way for future advancements in this critical area.